This report aims to provide a comprehensive presentation of the global market for Non Invasive Colon Cancer Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non Invasive Colon Cancer Screening. This report contains market size and forecasts of Non Invasive Colon Cancer Screening in global, including the following market information:
Global Non Invasive Colon Cancer Screening Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Non Invasive Colon Cancer Screening market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Fecal Immunochemical Test (FIT) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Non Invasive Colon Cancer Screening include Abbott Laboratories, Beckman Coulter, Inc., Epigenomics AG, Sysmex Corporation, Quest Diagnostics, Exact Sciences Corporation, Novigenix SA and CML Healthcare, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Non Invasive Colon Cancer Screening companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non Invasive Colon Cancer Screening Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Non Invasive Colon Cancer Screening Market Segment Percentages, by Type, 2022 (%)
Fecal Immunochemical Test (FIT)
Guaiac-based Fecal Occult Blood Test (gFOBT)
Global Non Invasive Colon Cancer Screening Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Non Invasive Colon Cancer Screening Market Segment Percentages, by Application, 2022 (%)
Hospitals
Speciality Clinics
Ambulatory Surgical Centers
Diagnostic Centers
Others
Global Non Invasive Colon Cancer Screening Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Non Invasive Colon Cancer Screening Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non Invasive Colon Cancer Screening revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Non Invasive Colon Cancer Screening revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Beckman Coulter, Inc.
Epigenomics AG
Sysmex Corporation
Quest Diagnostics
Exact Sciences Corporation
Novigenix SA
CML Healthcare, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non Invasive Colon Cancer Screening, market overview.
Chapter 2: Global Non Invasive Colon Cancer Screening market size in revenue.
Chapter 3: Detailed analysis of Non Invasive Colon Cancer Screening company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non Invasive Colon Cancer Screening in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Non Invasive Colon Cancer Screening Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non Invasive Colon Cancer Screening Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non Invasive Colon Cancer Screening Overall Market Size
2.1 Global Non Invasive Colon Cancer Screening Market Size: 2022 VS 2029
2.2 Global Non Invasive Colon Cancer Screening Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non Invasive Colon Cancer Screening Players in Global Market
3.2 Top Global Non Invasive Colon Cancer Screening Companies Ranked by Revenue
3.3 Global Non Invasive Colon Cancer Screening Revenue by Companies
3.4 Top 3 and Top 5 Non Invasive Colon Cancer Screening Companies in Global Market, by Revenue in 2022
3.5 Global Companies Non Invasive Colon Cancer Screening Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non Invasive Colon Cancer Screening Players in Global Market
3.6.1 List of Global Tier 1 Non Invasive Colon Cancer Screening Companies
3.6.2 List of Global Tier 2 and Tier 3 Non Invasive Colon Cancer Screening Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Non Invasive Colon Cancer Screening Market Size Markets, 2022 & 2029
4.1.2 Fecal Immunochemical Test (FIT)
4.1.3 Guaiac-based Fecal Occult Blood Test (gFOBT)
4.2 By Type - Global Non Invasive Colon Cancer Screening Revenue & Forecasts
4.2.1 By Type - Global Non Invasive Colon Cancer Screening Revenue, 2018-2023
4.2.2 By Type - Global Non Invasive Colon Cancer Screening Revenue, 2024-2029
4.2.3 By Type - Global Non Invasive Colon Cancer Screening Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non Invasive Colon Cancer Screening Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Speciality Clinics
5.1.4 Ambulatory Surgical Centers
5.1.5 Diagnostic Centers
5.1.6 Others
5.2 By Application - Global Non Invasive Colon Cancer Screening Revenue & Forecasts
5.2.1 By Application - Global Non Invasive Colon Cancer Screening Revenue, 2018-2023
5.2.2 By Application - Global Non Invasive Colon Cancer Screening Revenue, 2024-2029
5.2.3 By Application - Global Non Invasive Colon Cancer Screening Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Non Invasive Colon Cancer Screening Market Size, 2022 & 2029
6.2 By Region - Global Non Invasive Colon Cancer Screening Revenue & Forecasts
6.2.1 By Region - Global Non Invasive Colon Cancer Screening Revenue, 2018-2023
6.2.2 By Region - Global Non Invasive Colon Cancer Screening Revenue, 2024-2029
6.2.3 By Region - Global Non Invasive Colon Cancer Screening Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Non Invasive Colon Cancer Screening Revenue, 2018-2029
6.3.2 US Non Invasive Colon Cancer Screening Market Size, 2018-2029
6.3.3 Canada Non Invasive Colon Cancer Screening Market Size, 2018-2029
6.3.4 Mexico Non Invasive Colon Cancer Screening Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Non Invasive Colon Cancer Screening Revenue, 2018-2029
6.4.2 Germany Non Invasive Colon Cancer Screening Market Size, 2018-2029
6.4.3 France Non Invasive Colon Cancer Screening Market Size, 2018-2029
6.4.4 U.K. Non Invasive Colon Cancer Screening Market Size, 2018-2029
6.4.5 Italy Non Invasive Colon Cancer Screening Market Size, 2018-2029
6.4.6 Russia Non Invasive Colon Cancer Screening Market Size, 2018-2029
6.4.7 Nordic Countries Non Invasive Colon Cancer Screening Market Size, 2018-2029
6.4.8 Benelux Non Invasive Colon Cancer Screening Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Non Invasive Colon Cancer Screening Revenue, 2018-2029
6.5.2 China Non Invasive Colon Cancer Screening Market Size, 2018-2029
6.5.3 Japan Non Invasive Colon Cancer Screening Market Size, 2018-2029
6.5.4 South Korea Non Invasive Colon Cancer Screening Market Size, 2018-2029
6.5.5 Southeast Asia Non Invasive Colon Cancer Screening Market Size, 2018-2029
6.5.6 India Non Invasive Colon Cancer Screening Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Non Invasive Colon Cancer Screening Revenue, 2018-2029
6.6.2 Brazil Non Invasive Colon Cancer Screening Market Size, 2018-2029
6.6.3 Argentina Non Invasive Colon Cancer Screening Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non Invasive Colon Cancer Screening Revenue, 2018-2029
6.7.2 Turkey Non Invasive Colon Cancer Screening Market Size, 2018-2029
6.7.3 Israel Non Invasive Colon Cancer Screening Market Size, 2018-2029
6.7.4 Saudi Arabia Non Invasive Colon Cancer Screening Market Size, 2018-2029
6.7.5 UAE Non Invasive Colon Cancer Screening Market Size, 2018-2029
7 Non Invasive Colon Cancer Screening Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Non Invasive Colon Cancer Screening Major Product Offerings
7.1.4 Abbott Laboratories Non Invasive Colon Cancer Screening Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Beckman Coulter, Inc.
7.2.1 Beckman Coulter, Inc. Company Summary
7.2.2 Beckman Coulter, Inc. Business Overview
7.2.3 Beckman Coulter, Inc. Non Invasive Colon Cancer Screening Major Product Offerings
7.2.4 Beckman Coulter, Inc. Non Invasive Colon Cancer Screening Revenue in Global Market (2018-2023)
7.2.5 Beckman Coulter, Inc. Key News & Latest Developments
7.3 Epigenomics AG
7.3.1 Epigenomics AG Company Summary
7.3.2 Epigenomics AG Business Overview
7.3.3 Epigenomics AG Non Invasive Colon Cancer Screening Major Product Offerings
7.3.4 Epigenomics AG Non Invasive Colon Cancer Screening Revenue in Global Market (2018-2023)
7.3.5 Epigenomics AG Key News & Latest Developments
7.4 Sysmex Corporation
7.4.1 Sysmex Corporation Company Summary
7.4.2 Sysmex Corporation Business Overview
7.4.3 Sysmex Corporation Non Invasive Colon Cancer Screening Major Product Offerings
7.4.4 Sysmex Corporation Non Invasive Colon Cancer Screening Revenue in Global Market (2018-2023)
7.4.5 Sysmex Corporation Key News & Latest Developments
7.5 Quest Diagnostics
7.5.1 Quest Diagnostics Company Summary
7.5.2 Quest Diagnostics Business Overview
7.5.3 Quest Diagnostics Non Invasive Colon Cancer Screening Major Product Offerings
7.5.4 Quest Diagnostics Non Invasive Colon Cancer Screening Revenue in Global Market (2018-2023)
7.5.5 Quest Diagnostics Key News & Latest Developments
7.6 Exact Sciences Corporation
7.6.1 Exact Sciences Corporation Company Summary
7.6.2 Exact Sciences Corporation Business Overview
7.6.3 Exact Sciences Corporation Non Invasive Colon Cancer Screening Major Product Offerings
7.6.4 Exact Sciences Corporation Non Invasive Colon Cancer Screening Revenue in Global Market (2018-2023)
7.6.5 Exact Sciences Corporation Key News & Latest Developments
7.7 Novigenix SA
7.7.1 Novigenix SA Company Summary
7.7.2 Novigenix SA Business Overview
7.7.3 Novigenix SA Non Invasive Colon Cancer Screening Major Product Offerings
7.7.4 Novigenix SA Non Invasive Colon Cancer Screening Revenue in Global Market (2018-2023)
7.7.5 Novigenix SA Key News & Latest Developments
7.8 CML Healthcare, Inc.
7.8.1 CML Healthcare, Inc. Company Summary
7.8.2 CML Healthcare, Inc. Business Overview
7.8.3 CML Healthcare, Inc. Non Invasive Colon Cancer Screening Major Product Offerings
7.8.4 CML Healthcare, Inc. Non Invasive Colon Cancer Screening Revenue in Global Market (2018-2023)
7.8.5 CML Healthcare, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Non Invasive Colon Cancer Screening Market Opportunities & Trends in Global Market
Table 2. Non Invasive Colon Cancer Screening Market Drivers in Global Market
Table 3. Non Invasive Colon Cancer Screening Market Restraints in Global Market
Table 4. Key Players of Non Invasive Colon Cancer Screening in Global Market
Table 5. Top Non Invasive Colon Cancer Screening Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Non Invasive Colon Cancer Screening Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Non Invasive Colon Cancer Screening Revenue Share by Companies, 2018-2023
Table 8. Global Companies Non Invasive Colon Cancer Screening Product Type
Table 9. List of Global Tier 1 Non Invasive Colon Cancer Screening Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non Invasive Colon Cancer Screening Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Non Invasive Colon Cancer Screening Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Non Invasive Colon Cancer Screening Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Non Invasive Colon Cancer Screening Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Non Invasive Colon Cancer Screening Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Non Invasive Colon Cancer Screening Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Non Invasive Colon Cancer Screening Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2024-2029
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Non Invasive Colon Cancer Screening Product Offerings
Table 32. Abbott Laboratories Non Invasive Colon Cancer Screening Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Beckman Coulter, Inc. Company Summary
Table 35. Beckman Coulter, Inc. Non Invasive Colon Cancer Screening Product Offerings
Table 36. Beckman Coulter, Inc. Non Invasive Colon Cancer Screening Revenue (US$, Mn) & (2018-2023)
Table 37. Beckman Coulter, Inc. Key News & Latest Developments
Table 38. Epigenomics AG Company Summary
Table 39. Epigenomics AG Non Invasive Colon Cancer Screening Product Offerings
Table 40. Epigenomics AG Non Invasive Colon Cancer Screening Revenue (US$, Mn) & (2018-2023)
Table 41. Epigenomics AG Key News & Latest Developments
Table 42. Sysmex Corporation Company Summary
Table 43. Sysmex Corporation Non Invasive Colon Cancer Screening Product Offerings
Table 44. Sysmex Corporation Non Invasive Colon Cancer Screening Revenue (US$, Mn) & (2018-2023)
Table 45. Sysmex Corporation Key News & Latest Developments
Table 46. Quest Diagnostics Company Summary
Table 47. Quest Diagnostics Non Invasive Colon Cancer Screening Product Offerings
Table 48. Quest Diagnostics Non Invasive Colon Cancer Screening Revenue (US$, Mn) & (2018-2023)
Table 49. Quest Diagnostics Key News & Latest Developments
Table 50. Exact Sciences Corporation Company Summary
Table 51. Exact Sciences Corporation Non Invasive Colon Cancer Screening Product Offerings
Table 52. Exact Sciences Corporation Non Invasive Colon Cancer Screening Revenue (US$, Mn) & (2018-2023)
Table 53. Exact Sciences Corporation Key News & Latest Developments
Table 54. Novigenix SA Company Summary
Table 55. Novigenix SA Non Invasive Colon Cancer Screening Product Offerings
Table 56. Novigenix SA Non Invasive Colon Cancer Screening Revenue (US$, Mn) & (2018-2023)
Table 57. Novigenix SA Key News & Latest Developments
Table 58. CML Healthcare, Inc. Company Summary
Table 59. CML Healthcare, Inc. Non Invasive Colon Cancer Screening Product Offerings
Table 60. CML Healthcare, Inc. Non Invasive Colon Cancer Screening Revenue (US$, Mn) & (2018-2023)
Table 61. CML Healthcare, Inc. Key News & Latest Developments
List of Figures
Figure 1. Non Invasive Colon Cancer Screening Segment by Type in 2022
Figure 2. Non Invasive Colon Cancer Screening Segment by Application in 2022
Figure 3. Global Non Invasive Colon Cancer Screening Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Non Invasive Colon Cancer Screening Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Non Invasive Colon Cancer Screening Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non Invasive Colon Cancer Screening Revenue in 2022
Figure 8. By Type - Global Non Invasive Colon Cancer Screening Revenue Market Share, 2018-2029
Figure 9. By Application - Global Non Invasive Colon Cancer Screening Revenue Market Share, 2018-2029
Figure 10. By Type - Global Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Non Invasive Colon Cancer Screening Revenue Market Share, 2018-2029
Figure 12. By Application - Global Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Non Invasive Colon Cancer Screening Revenue Market Share, 2018-2029
Figure 14. By Region - Global Non Invasive Colon Cancer Screening Revenue Market Share, 2018-2029
Figure 15. By Country - North America Non Invasive Colon Cancer Screening Revenue Market Share, 2018-2029
Figure 16. US Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Non Invasive Colon Cancer Screening Revenue Market Share, 2018-2029
Figure 20. Germany Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 21. France Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Non Invasive Colon Cancer Screening Revenue Market Share, 2018-2029
Figure 28. China Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 32. India Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Non Invasive Colon Cancer Screening Revenue Market Share, 2018-2029
Figure 34. Brazil Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Non Invasive Colon Cancer Screening Revenue Market Share, 2018-2029
Figure 37. Turkey Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Non Invasive Colon Cancer Screening Revenue, (US$, Mn), 2018-2029
Figure 41. Abbott Laboratories Non Invasive Colon Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Beckman Coulter, Inc. Non Invasive Colon Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Epigenomics AG Non Invasive Colon Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sysmex Corporation Non Invasive Colon Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Quest Diagnostics Non Invasive Colon Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Exact Sciences Corporation Non Invasive Colon Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novigenix SA Non Invasive Colon Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. CML Healthcare, Inc. Non Invasive Colon Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
